Catalyst Wire Dossier Catalyst Wire Dossier

Fixed-dose combination ARB + thiazide diuretic

· Eurofarma Laboratorios S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fixed-dose combination ARB + thiazide diuretic, covering 2024-11-27 to 2024-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension [Phase 3]

See pricing